Curaleaf Expands Product Offerings With Launch of BlueKudu Chocolates in Florida
BlueKudu's artisanal infused chocolates will be available at all 45 Curaleaf locations statewide
WAKEFIELD, Mass., April 20, 2022 /CNW/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today announced the launch of BlueKudu infused chocolates at all 45 Curaleaf locations in Florida. Acquired by Curaleaf in 2020, BlueKudu was founded in Colorado as one of the state's original and most experienced edible manufacturers known for utilizing culinary experts to create artisanal cannabis products. The expansion marks BlueKudu's first launch outside of Colorado and Curaleaf's entrance into Florida's infused chocolate category.
Patients in the Sunshine State can now experience the BlueKudu brand through three distinct 100mg gluten-free bars: Milk Chocolate (sativa), vegan Dark Chocolate Mint (hybrid) and Milk Chocolate (indica). Each BlueKudu chocolate bar consists of high-quality ingredients sourced from Rainforest Alliance Fair Trade Certified Farms. BlueKudu's alcohol extraction process produces a clean and more natural oil infused in easy-to-manage 5mg pieces that simplify the dosing process.
"BlueKudu's ability to produce consistent and premium edibles make it an ideal patient offering in Florida," said Joe Bayern, CEO of Curaleaf US. "We are thrilled to introduce the brand's line of artisanal infused chocolates to the state's growing base of medical patients. At Curaleaf, and especially in the important Florida market, we remain committed to enhancing our product offerings to meet the needs of the diverse patient community."
The expansion of BlueKudu follows the launch of Select Live Rosin and Select X Bites in Florida. For more information regarding Curaleaf's latest product offerings in the state, along with openings and hours of operation, please visit www.curaleaf.com/locations/#florida.
About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 128 dispensaries, 26 cultivation sites, and employs over 5,600 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the launch of BlueKudu in Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed March 9, 2022, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
INVESTOR CONTACT
Curaleaf Holdings, Inc.
Investor Relations
[email protected]
MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
[email protected]
SOURCE Curaleaf Holdings, Inc.
![](https://rt.newswire.ca/rt.gif?NewsItemId=C5775&Transmission_Id=202204200800CANADANWCANADAPR_C5775&DateId=20220420)
Share this article